High Percentage of Treatment Interruption
|High Percentage of Treatment Interruption (kri)
|Type of indicator
|the treatment with the investigational product is interrupted
|DUE TO Risk Causes
|the occurrence of adverse events or serious adverse events
|THEN Risk Impact MAY RESULT
|not enough Subjects or poor statistical significance
|High Percentage of Treatment Interruption
|Percent of Treatment Interruption
|What level should be measured
|Study, Country, Site, Subject
|only enrolled Subjects should be considered for the KRI
|Monitor and mitigate the risk associated with a significant proportion of Subjects experiencing interruptions in their treatment regimen.
|KRI monitors the percentage of Subjects experiencing interruptions in their treatment regimen to identify and address potential risks.
|Devide a number of enrolled Subjects with treatment status “incomplete” (or any interraptions) by a number of enrolled Subjects.
|Suggested Thresholds - High
|Suggested Thresholds - Medium
|Associated Metric 1
|Number of enrolled Subjects
|Associated Metric 2
|Number of enrolled Subjects with treatment status “incomplete” (or any interraptions)
Do you like the KRI description?
There was a problem submitting your feedback. Please try again later.